Navigating the drug’s launch in NHS
The NHS drugs bill is estimated to be £20 billion in 2020/21. This is a massive market for any pharmaceutical company big or small to ignore but same time complex to penetrate. A new innovative drug doesn’t guarantee anyone will buy the medicine. For commercial...
Guidance anomalies-analytic tools to alert priorities.
How does Commercial Pharma align to NHS guidance opportunities? Formulary Analytics enables companies to be agile and increasingly aligned with 'their NHS customers. Non-alignment of your product across formulary and guidance status creates scenarios that reduce...
Home | Key Offerings | Use Cases | Team | Case Study | Contact
Copyright 2023 Allot Ltd. All rights reserved.
ALLOT® is the registered trademark of Allot Limited.
Company registered in England and Wales with company number 06951007 and VAT number 195 1921 86.